curation. Author Contributions Conceptualization: Amand F. Schmidt, Hiddo J. L. Heerspink, Chris Finan, Rolf H. H. Groenwold. Data curation: Amand F. Schmidt, Petra Denig, Chris Finan. Formal analysis ... : Amand F. Schmidt. Investigation: Hiddo J. L. Heerspink, Petra Denig. Methodology: Amand F. Schmidt, Rolf H. H. Groenwold. Supervision: Hiddo J. L. Heerspink, Petra Denig, Chris Finan, Rolf H. H
/creatinine ratio VEGFA Vascular endothelial growth factor A Hiddo J. L. Heerspink and Paul Perco contributed equally to this work. Electronic supplementary material The online version of this article
, 9700 AD Groningen , the Netherlands 1 Ron T. Gansevoort 2 Hiddo J. L. Heerspink 3 Division Nephrology, Department of Internal Medicine, University of Groningen, University Medical Center Groningen , PO
Box 30001, 9700 RB Groningen , the Netherlands 1 Hiddo J. L. Heerspink CCL2; Diabetic kidney disease; Inflammation; JAK-STAT; MCP-1 - were assessed in patients with proteinuria more than 30 years ago
Aldosterone is elevated in chronic kidney disease (CKD) and may be involved in hypertension. Surprisingly, the determinants of the plasma aldosterone concentration (PAC) and its role in hypertension are not well studied in CKD. Therefore, we studied the determinants of aldosterone and its association with blood pressure in CKD patients. We also studied this during renin...
Center Groningen , P.O. Box 30.001, 9700 RB Groningen , the Netherlands 2 Hiddo J. L. Heerspink 3 Mosaiques Diagnostics GmbH , Hannover , Germany The past decade has resulted in multiple new findings of
Background Fluid retention is a common adverse event in patients who receive endothelin (ET) receptor antagonist therapy, including the highly selective ETA receptor antagonist, atrasentan. Objective We performed longitudinal assessments of thoracic bioimpedance in patients with type 2 diabetes mellitus and nephropathy to determine whether a decrease in bioimpedance accurately...